Most Recent Articles by Jody A. Charnow, Editor
Sparsentan could become the first FDA-approved medication for the focal segmental glomerularsclerosis.
Updated label for patiromer now recommends the drug be taken at least 3 hours before or after other oral medications.
HIV-infected men and women had lower incidences of colorectal and lung cancer compared with the general population.
The condition also is associated with greater use of renal-replacement therapy and mechanical ventilation.
Younger patients are less likely to respond to treatment with sucroferric oxyhydroxide or sevelamer.
More Articles by Jody A. Charnow, Editor
Renal and Urology News Articles
- CB-839 Drug Promising for Clear Cell, Papillary Renal Cell Cancer
- Guideline Confirmed for UTI in Children With Fever
- Survival Benefit Linked With Adjuvant RT+ADT in Lymph Node + PCa
- Reoperation Risk Highest After POP Repair With Vaginal Mesh and Sling
- AKI Is a Risk Factor for Delirium, Coma in Critically Ill
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)